Surgery Partners Stock Technical Analysis

SGRY Stock  USD 16.20  0.06  0.37%   
As of the 28th of January, Surgery Partners has the Variance of 13.86, coefficient of variation of (1,169), and Risk Adjusted Performance of (0.05). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgery Partners, as well as the relationship between them.

Surgery Partners Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Surgery, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SurgerySurgery Partners' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Surgery Partners Analyst Consensus

Target PriceAdvice# of Analysts
25.45Strong Buy12Odds
Surgery Partners current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Surgery analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Surgery stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Surgery Partners, talking to its executives and customers, or listening to Surgery conference calls.
Surgery Analyst Advice Details
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.36)
Revenue Per Share
25.941
Quarterly Revenue Growth
0.066
Return On Assets
0.0419
Return On Equity
0.0066
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Surgery Partners 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Surgery Partners' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Surgery Partners.
0.00
10/30/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/28/2026
0.00
If you would invest  0.00  in Surgery Partners on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Surgery Partners or generate 0.0% return on investment in Surgery Partners over 90 days. Surgery Partners is related to or competes with LivaNova PLC, Alphatec Holdings, Brookdale Senior, Scholar Rock, Ardent Health, Ideaya Biosciences, and Heartflow Common. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary servi... More

Surgery Partners Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Surgery Partners' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Surgery Partners upside and downside potential and time the market with a certain degree of confidence.

Surgery Partners Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgery Partners' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Surgery Partners' standard deviation. In reality, there are many statistical measures that can use Surgery Partners historical prices to predict the future Surgery Partners' volatility.
Hype
Prediction
LowEstimatedHigh
12.3416.2020.06
Details
Intrinsic
Valuation
LowRealHigh
10.8914.7518.61
Details
Naive
Forecast
LowNextHigh
12.5916.4520.31
Details
12 Analysts
Consensus
LowTargetHigh
23.1625.4528.25
Details

Surgery Partners January 28, 2026 Technical Indicators

Surgery Partners Backtested Returns

Surgery Partners owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Surgery Partners exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Surgery Partners' Risk Adjusted Performance of (0.05), coefficient of variation of (1,169), and Variance of 13.86 to confirm the risk estimate we provide. The entity has a beta of -0.72, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Surgery Partners are expected to decrease at a much lower rate. During the bear market, Surgery Partners is likely to outperform the market. At this point, Surgery Partners has a negative expected return of -0.44%. Please make sure to validate Surgery Partners' maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Surgery Partners performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.07  

Very weak reverse predictability

Surgery Partners has very weak reverse predictability. Overlapping area represents the amount of predictability between Surgery Partners time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Surgery Partners price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Surgery Partners price fluctuation can be explain by its past prices.
Correlation Coefficient-0.07
Spearman Rank Test-0.36
Residual Average0.0
Price Variance0.07
Surgery Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Surgery Partners technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Surgery Partners trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Surgery Partners Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Surgery Partners volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Surgery Partners Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Surgery Partners on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Surgery Partners based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Surgery Partners price pattern first instead of the macroeconomic environment surrounding Surgery Partners. By analyzing Surgery Partners's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Surgery Partners's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Surgery Partners specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Dividend Yield0.0015160.00144
Price To Sales Ratio0.991.47

Surgery Partners January 28, 2026 Technical Indicators

Most technical analysis of Surgery help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Surgery from various momentum indicators to cycle indicators. When you analyze Surgery charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Surgery Partners January 28, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Surgery stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.